hg_101925.1

Basic information about the TSS

---

TSS ID: hg_101925.1 Species: human Chr: chr9		Start: 110256555 End: 110256566 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK289508 Distance: 0 GeneID: 7295 HGNC/MGI_ID: HGNC:12435 UniProt_ID:

Gene_name: thioredoxin Gene_symbol: TXN Gene_synonyms: TRX Trx80 Gene_source: HGNC:12435

TATA-Box annotation

---

Distance to TSS:	-54
Nearest PromoterID:	NM_001244938
Entrez ID:	7295
Nearest Unigene:	Hs.435136
Nearest Refseq:	NM_003329
Nearest Ensembl:	ENSG00000136810
Gene Name:	thioredoxin
Gene Alias:	TRDX|TRX|TRX1
Gene Description:	thioredoxin
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.706468
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	19(CAGTTTATAAAG,-,0.00),21(GTTTATAAAGGG,+,0.00),21(GTTTATAAAGGG,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TXN p2@TXN p3@TXN
Sample		p1@TXN	p2@TXN	p3@TXN
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	186.23	30.19	64.87
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	171.77	31.16	62.52
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	178.44	35.11	61.15
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	212.69	24.53	58.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	215.52	20.92	57.14
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	220.75	30.04	60.08
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	357.98	48.15	77.78
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	289.21	32.22	61.52
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	230.60	28.42	57.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	104.33	16.81	26.66
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	75.19	10.51	26.28
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	86.60	10.16	25.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	112.83	24.66	28.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	120.88	29.32	29.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	129.98	30.52	30.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	118.20	19.87	28.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	115.97	22.28	31.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	131.19	24.47	21.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	133.82	21.86	29.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	165.94	31.74	40.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	134.32	29.54	29.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	170.21	36.42	39.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	123.70	28.18	28.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	132.01	24.27	28.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	145.25	28.89	29.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	169.97	28.17	39.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	187.37	31.32	37.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	145.93	25.70	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	162.01	29.72	30.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	141.33	30.22	32.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	172.71	27.42	35.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	149.27	24.81	31.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	162.91	23.64	35.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	286.17	46.84	58.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	165.67	31.04	30.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	113.63	26.83	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	161.87	35.56	32.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	155.75	29.22	37.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	210.14	36.46	40.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	183.17	29.05	37.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	153.62	25.64	27.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	260.29	35.72	51.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	211.74	23.41	31.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	193.36	30.42	34.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	240.53	36.54	45.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	255.91	35.59	46.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	195.28	23.03	33.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	276.59	36.66	51.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	210.41	27.77	34.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	229.29	29.93	35.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	255.99	33.00	32.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	212.15	23.35	36.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	377.79	125.93	69.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	117.46	13.48	24.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	143.49	15.58	29.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	421.99	117.45	154.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	416.07	61.08	73.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	141.31	12.64	23.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	111.12	13.81	14.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	295.47	45.89	54.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	106.46	10.58	17.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	121.13	7.85	20.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	242.03	57.32	65.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	257.20	29.56	48.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	91.30	11.05	15.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	93.71	14.20	15.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	226.30	258.62	113.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	300.10	205.33	78.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	98.97	19.99	38.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	109.59	19.83	36.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	86.79	26.27	43.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	123.20	37.09	81.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	94.66	22.27	50.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	77.05	21.40	35.47
Adipocyte - breast, donor1	11376-118A8	519.02	48.47	42.13
Adipocyte - breast, donor2	11327-117E4	186.90	28.72	27.43
Adipocyte - omental, donor1	11473-119C6	654.46	54.20	37.79
Adipocyte - omental, donor2	11474-119C7	378.98	26.91	43.35
Adipocyte - omental, donor3	11475-119C8	265.59	20.76	33.49
Adipocyte - perirenal, donor1	11476-119C9	273.70	23.61	51.68
Adipocyte - subcutaneous, donor1	11259-116F8	94.56	23.09	23.09
Adipocyte - subcutaneous, donor2	11336-117F4	284.52	21.68	25.29
Adipocyte - subcutaneous, donor3	11408-118E4	78.37	11.64	10.77
Adipocyte differentiation, day04, donor1	13019-139D4	213.17	40.09	27.58
Adipocyte differentiation, day04, donor2	13022-139D7	116.34	22.65	27.80
Adipocyte differentiation, day04, donor3	13025-139E1	321.15	29.27	39.03
Adipocyte differentiation, day04, donor4	13028-139E4	153.42	24.69	18.81
Adipocyte differentiation, day08, donor1	13020-139D5	124.99	24.21	22.84
Adipocyte differentiation, day08, donor2	13023-139D8	160.73	23.24	34.53
Adipocyte differentiation, day08, donor3	13026-139E2	181.82	28.79	28.26
Adipocyte differentiation, day08, donor4	13029-139E5	142.45	16.69	21.14
Adipocyte differentiation, day12, donor1	13021-139D6	91.08	18.30	25.37
Adipocyte differentiation, day12, donor2	13024-139D9	193.40	20.60	34.66
Adipocyte differentiation, day12, donor3	13027-139E3	171.48	19.31	16.69
Adipocyte differentiation, day12, donor4	13030-139E6	89.82	9.44	11.57
Alveolar Epithelial Cells, donor1	11510-119G7	302.10	56.58	77.79
Alveolar Epithelial Cells, donor2	11590-120G6	127.30	12.19	22.95
Alveolar Epithelial Cells, donor3	11671-122G6	165.33	31.15	22.76
Amniotic Epithelial Cells, donor1	11533-120A3	171.63	36.34	39.76
Amniotic Epithelial Cells, donor2	11613-122A2	76.98	13.39	18.41
Amniotic Epithelial Cells, donor3	11694-123A2	223.12	36.98	40.47
Anulus Pulposus Cell, donor1	11248-116E6	418.11	57.67	41.08
Anulus Pulposus Cell, donor2	11463-119B5	263.03	25.47	23.51
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	368.87	31.00	51.67
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	301.29	22.58	45.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	462.29	49.23	70.63
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	417.89	40.35	49.92
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	328.81	25.29	63.23
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	466.01	35.64	35.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	346.98	31.19	44.18
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	300.00	30.58	47.57
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	515.49	53.45	38.60
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	409.40	41.43	54.24
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	309.86	31.20	43.54
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	458.88	40.12	41.37
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	617.43	52.88	47.28
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	256.58	27.30	62.78
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	718.22	60.92	55.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	354.69	28.93	38.04
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	421.52	37.60	41.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	447.70	38.22	43.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	266.30	38.04	44.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	411.83	45.61	42.96
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	512.71	44.43	43.23
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	226.57	46.02	42.48
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	324.02	34.48	37.39
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	574.71	41.95	54.53
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	316.50	36.41	46.60
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	432.95	59.95	47.05
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	451.84	42.40	39.98
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	343.16	34.20	57.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	344.61	33.35	33.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	388.43	30.71	35.62
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	285.28	28.15	47.86
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	331.84	28.94	36.98
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	490.85	41.38	41.38
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	284.29	26.91	40.95
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	355.87	40.95	41.25
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	456.19	48.71	48.71
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	382.44	39.16	51.87
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	471.68	52.72	45.84
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	468.27	46.38	48.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	264.53	30.21	45.74
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	424.43	47.42	40.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	416.12	35.38	32.48
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	231.46	27.40	45.35
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	366.00	41.87	44.42
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	421.58	41.69	34.75
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	211.26	31.69	42.25
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	324.62	38.17	42.02
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	558.34	36.70	32.49
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	314.19	26.97	52.49
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	439.30	47.82	45.06
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	372.34	35.70	38.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	1097.01	67.12	58.73
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	368.29	37.57	37.57
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	416.16	39.78	33.66
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	339.39	31.07	57.36
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	329.28	32.60	37.25
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	566.07	54.93	42.72
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	329.56	28.25	42.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	333.38	35.48	33.89
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	408.88	23.26	31.26
Astrocyte - cerebellum, donor1	11500-119F6	323.99	42.74	61.04
Astrocyte - cerebellum, donor2	11580-120F5	106.80	18.14	35.60
Astrocyte - cerebellum, donor3	11661-122F5	126.69	20.97	19.72
Astrocyte - cerebral cortex, donor1	11235-116D2	187.89	61.35	48.10
Astrocyte - cerebral cortex, donor2	11316-117D2	151.42	52.74	61.15
Astrocyte - cerebral cortex, donor3	11392-118C6	108.29	47.88	53.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	252.88	88.42	79.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	290.15	76.80	69.66
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	264.35	80.45	75.11
Basophils, donor1	12241-129G9	61.20	25.63	20.14
Basophils, donor2	12242-129H1	77.57	39.69	24.89
Basophils, donor3	12243-129H2	56.59	17.35	12.64
Bronchial Epithelial Cell, donor1	11511-119G8	326.85	35.14	32.77
Bronchial Epithelial Cell, donor2	11591-120G7	105.61	5.94	13.26
Bronchial Epithelial Cell, donor3	11672-122G7	1635.57	86.08	50.21
Bronchial Epithelial Cell, donor4	11453-119A4	658.41	49.58	70.30
Bronchial Epithelial Cell, donor5	11457-119A8	89.63	6.24	11.85
Bronchial Epithelial Cell, donor6	11461-119B3	167.42	13.13	28.79
Bronchial Epithelial Cell, donor7	11769-123I5	877.41	53.98	70.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	176.74	56.17	95.33
Burkitt's lymphoma cell line:RAJI	10476-106I8	398.96	111.33	131.36
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	465.59	139.74	92.10
CD133+ stem cells - cord blood derived, pool1	12223-129E9	341.28	82.74	103.42
CD14+ Monocytes, donor1	11224-116B9	75.52	19.72	19.72
CD14+ Monocytes, donor2	11305-117B9	24.68	9.47	9.47
CD14+ Monocytes, donor3	11381-118B4	29.86	10.98	12.07
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	794.79	43.87	45.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	1293.02	48.14	39.80
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	724.54	49.31	35.83
CD14+ monocytes - mock treated, donor1	11863-125A9	75.31	14.45	19.23
CD14+ monocytes - mock treated, donor2	11873-125C1	77.25	11.47	15.39
CD14+ monocytes - mock treated, donor3	11883-125D2	52.35	14.45	16.11
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	125.55	10.04	19.75
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	214.46	15.18	24.29
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	379.83	29.01	39.42
CD14+ monocytes - treated with BCG, donor1	11860-125A6	550.00	26.63	31.33
CD14+ monocytes - treated with BCG, donor2	11870-125B7	409.33	19.23	29.56
CD14+ monocytes - treated with BCG, donor3	11880-125C8	864.43	51.36	63.77
CD14+ monocytes - treated with Candida, donor1	11868-125B5	338.08	12.17	21.77
CD14+ monocytes - treated with Candida, donor2	11878-125C6	434.57	15.31	30.63
CD14+ monocytes - treated with Candida, donor3	11888-125D7	462.60	31.06	31.06
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	93.12	13.09	20.38
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	200.74	16.36	31.13
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	459.70	56.21	55.17
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	426.68	21.96	34.32
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	588.81	28.28	31.22
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	423.37	24.01	18.77
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	207.93	20.71	28.51
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	285.42	23.03	29.66
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	189.37	24.83	26.51
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	296.88	25.17	31.41
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	553.41	29.24	34.17
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	568.15	33.78	50.89
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	417.97	22.49	23.02
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	316.67	17.47	30.48
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	793.22	59.71	57.34
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	289.92	22.93	31.12
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	579.03	33.15	41.96
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	747.25	54.98	63.57
CD14+CD16+ Monocytes, donor1	11789-124B7	39.89	27.90	29.21
CD14+CD16+ Monocytes, donor2	11801-124D1	48.05	19.87	20.10
CD14+CD16+ Monocytes, donor3	11912-125G4	59.57	34.01	32.71
CD14+CD16- Monocytes, donor1	11788-124B6	75.84	29.59	35.97
CD14+CD16- Monocytes, donor2	11799-124C8	70.21	22.53	27.59
CD14+CD16- Monocytes, donor3	11910-125G2	53.29	32.33	32.55
CD14-CD16+ Monocytes, donor1	11790-124B8	40.32	22.46	25.26
CD14-CD16+ Monocytes, donor2	11800-124C9	31.18	16.25	14.27
CD14-CD16+ Monocytes, donor3	11911-125G3	26.74	19.58	21.69
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	56.90	32.52	30.48
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	58.31	29.15	34.58
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	61.10	29.00	30.03
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	79.42	26.65	26.65
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	50.93	24.66	28.95
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	63.17	29.48	30.89
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.08	21.96	28.24
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	81.73	17.14	44.82
CD19+ B Cells, donor1	11544-120B5	3.29	5.75	6.58
CD19+ B Cells, donor2	11624-122B4	10.88	8.71	7.98
CD19+ B Cells, donor3	11705-123B4	5.55	8.58	8.58
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	451.33	153.95	156.77
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	532.92	162.99	154.20
CD34+ Progenitors, donor1	11545-120B6	341.38	56.23	55.22
CD34+ Progenitors, donor2	11625-122B5	282.59	43.82	61.80
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	304.74	96.94	88.68
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	484.11	153.78	122.66
CD4+ T Cells, donor1	11225-116C1	22.14	10.35	8.21
CD4+ T Cells, donor2	11306-117C1	40.42	11.63	15.31
CD4+ T Cells, donor3	11382-118B5	31.41	13.11	16.47
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	171.52	65.09	67.89
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	192.93	70.97	59.97
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	147.75	47.72	58.64
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	25.13	22.28	22.76
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.73	31.60	37.22
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	16.48	13.18
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	161.13	48.70	46.39
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	144.89	53.72	55.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	148.63	54.97	59.65
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	80.69	37.66	32.73
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	106.91	41.93	57.65
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	67.32	42.68	49.28
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	70.41	29.51	49.33
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	76.25	36.98	44.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	108.26	35.42	53.46
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	16.59	11.69	15.50
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	12.86	16.08	18.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	14.35	10.76
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	157.06	55.81	60.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	149.90	62.39	61.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	151.94	59.68	62.20
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	73.31	43.48	34.89
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	93.58	46.36	45.06
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	72.35	44.02	42.27
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	94.52	44.04	45.03
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	82.16	38.77	54.47
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	80.96	72.58	61.42
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	70.62	32.40	40.15
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	65.27	31.16	45.40
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	81.62	52.36	47.74
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	110.66	48.70	55.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	109.41	65.09	59.55
CD8+ T Cells, donor1	11226-116C2	29.79	11.13	15.39
CD8+ T Cells, donor2	11307-117C2	29.28	13.89	13.52
CD8+ T Cells, donor3	11383-118B6	21.21	10.10	8.08
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1652.77	15.60	27.07
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1532.51	12.46	19.65
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1956.73	21.07	28.18
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	2573.41	24.62	43.23
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	1465.09	10.32	24.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	1603.07	15.92	27.74
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2111.35	20.86	26.29
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2199.60	15.00	30.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2046.15	14.77	29.08
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2171.71	19.32	26.26
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1942.02	15.69	25.56
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1562.90	26.64	33.84
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1340.83	12.69	15.32
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1479.69	18.67	20.95
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1315.72	9.70	20.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1636.19	20.53	25.21
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1640.59	13.52	23.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1648.93	21.92	24.51
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1928.04	26.94	38.98
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1817.70	23.07	27.37
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	1599.07	17.95	32.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1901.24	16.45	33.27
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1649.33	17.73	27.19
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	1748.07	10.59	19.67
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	918.58	8.03	23.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	935.84	16.09	25.18
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	694.21	13.02	35.06
Cardiac Myocyte, donor1	11525-119I4	244.92	25.59	25.59
Cardiac Myocyte, donor2	11605-120I3	223.33	39.03	53.36
Cardiac Myocyte, donor3	11686-122I3	402.20	68.82	57.88
Chondrocyte - de diff, donor1	11261-116G1	826.80	37.44	28.77
Chondrocyte - de diff, donor2	11338-117F6	324.10	22.03	22.74
Chondrocyte - de diff, donor3	11410-118E6	430.99	29.24	16.38
Chondrocyte - re diff, donor2	11339-117F7	249.78	28.65	41.18
Chondrocyte - re diff, donor3	11411-118E7	136.28	28.31	23.86
Ciliary Epithelial Cells, donor1	11242-116D9	312.49	84.12	66.45
Ciliary Epithelial Cells, donor2	11323-117D9	242.20	67.34	55.58
Ciliary Epithelial Cells, donor3	11399-118D4	147.26	37.97	34.34
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	128.75	18.16	12.20
Corneal Epithelial Cells, donor1	11526-119I5	196.74	24.59	34.25
Corneal Epithelial Cells, donor2	11606-120I4	200.22	22.75	23.89
Corneal Epithelial Cells, donor3	11687-122I4	334.36	35.53	39.11
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4544.42	15.52	10.24
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4850.68	15.77	11.35
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	8443.86	34.51	20.70
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1445.33	13.07	10.80
Dendritic Cells - plasmacytoid, donor1	11228-116C4	473.17	59.45	59.10
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1540.77	201.08	131.23
Dendritic Cells - plasmacytoid, donor3	11385-118B8	783.99	68.72	110.34
Endothelial Cells - Aortic, donor0	11207-116A1	229.64	27.18	33.35
Endothelial Cells - Aortic, donor1	11263-116G3	112.07	26.40	34.62
Endothelial Cells - Aortic, donor2	11340-117F8	131.22	23.75	35.35
Endothelial Cells - Aortic, donor3	11412-118E8	98.69	14.94	15.33
Endothelial Cells - Artery, donor1	11264-116G4	79.12	19.49	23.85
Endothelial Cells - Artery, donor2	11341-117F9	88.23	26.82	33.88
Endothelial Cells - Artery, donor3	11413-118E9	116.23	23.32	30.33
Endothelial Cells - Lymphatic, donor1	11236-116D3	306.77	36.13	38.35
Endothelial Cells - Lymphatic, donor2	11317-117D3	275.06	37.12	30.12
Endothelial Cells - Lymphatic, donor3	11393-118C7	119.25	30.16	26.50
Endothelial Cells - Microvascular, donor1	11265-116G5	237.11	26.44	45.16
Endothelial Cells - Microvascular, donor2	11342-117G1	205.14	40.61	52.59
Endothelial Cells - Microvascular, donor3	11414-118F1	56.29	12.19	14.04
Endothelial Cells - Thoracic, donor1	11266-116G6	338.90	51.22	78.82
Endothelial Cells - Thoracic, donor2	11343-117G2	65.52	12.58	18.34
Endothelial Cells - Umbilical vein, donor1	11243-116E1	244.52	68.96	73.68
Endothelial Cells - Umbilical vein, donor2	11324-117E1	97.12	28.46	32.59
Endothelial Cells - Umbilical vein, donor3	11400-118D5	99.41	31.26	39.94
Endothelial Cells - Vein, donor1	11267-116G7	69.39	10.24	18.20
Endothelial Cells - Vein, donor2	11344-117G3	58.67	7.68	11.87
Endothelial Cells - Vein, donor3	11416-118F3	111.95	28.26	38.31
Eosinophils, donor1	12244-129H3	91.48	45.74	0.00
Eosinophils, donor2	12245-129H4	150.17	66.01	61.06
Eosinophils, donor3	12246-129H5	281.78	85.60	78.47
Esophageal Epithelial Cells, donor1	11507-119G4	300.03	32.50	32.74
Esophageal Epithelial Cells, donor2	11587-120G3	110.25	4.16	12.48
Esophageal Epithelial Cells, donor3	11668-122G3	959.86	48.81	32.54
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	231.94	29.56	23.81
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	730.84	25.73	25.95
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	627.28	43.44	40.41
Fibroblast - Aortic Adventitial, donor1	11245-116E3	596.21	68.89	46.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	646.74	26.20	17.20
Fibroblast - Aortic Adventitial, donor2	11326-117E3	314.82	25.84	19.62
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	236.35	16.07	15.81
Fibroblast - Aortic Adventitial, donor3	11401-118D6	400.97	40.86	43.19
Fibroblast - Cardiac, donor1	11268-116G8	350.65	44.00	30.39
Fibroblast - Cardiac, donor2	11345-117G4	112.18	19.71	20.46
Fibroblast - Cardiac, donor3	11417-118F4	136.27	21.92	21.13
Fibroblast - Cardiac, donor4	11452-119A3	381.92	47.28	25.76
Fibroblast - Cardiac, donor5	11456-119A7	169.80	29.31	44.42
Fibroblast - Cardiac, donor6	11460-119B2	352.30	42.75	58.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	222.16	21.57	25.86
Fibroblast - Choroid Plexus, donor2	11572-120E6	151.86	31.49	26.75
Fibroblast - Choroid Plexus, donor3	11653-122E6	117.18	60.06	80.56
Fibroblast - Conjunctival, donor1	11531-120A1	102.63	23.53	28.60
Fibroblast - Conjunctival, donor3	11692-122I9	338.53	34.26	24.93
Fibroblast - Dermal, donor1	11269-116G9	335.74	49.77	47.66
Fibroblast - Dermal, donor2	11346-117G5	222.16	41.04	48.58
Fibroblast - Dermal, donor3	11418-118F5	332.44	49.81	45.69
Fibroblast - Dermal, donor4	11450-119A1	154.31	41.15	65.00
Fibroblast - Dermal, donor5	11454-119A5	177.07	47.10	88.10
Fibroblast - Dermal, donor6	11458-119A9	213.91	61.88	108.82
Fibroblast - Gingival, donor1	11237-116D4	556.39	64.55	51.85
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	385.14	56.07	36.16
Fibroblast - Gingival, donor2	11318-117D4	308.37	78.41	90.14
Fibroblast - Gingival, donor3	11394-118C8	226.83	22.72	28.23
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	632.69	40.52	41.56
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	292.32	19.73	19.03
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	605.19	75.61	53.32
Fibroblast - Gingival, donor6 (control)	11922-125H5	683.98	60.18	61.53
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	39.52	4.23	7.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	459.06	54.26	51.48
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	532.46	62.18	57.54
Fibroblast - Gingival, donor8 (control)	11926-125H9	483.31	60.22	55.07
Fibroblast - Gingival, donor9 (control)	11927-125I1	379.91	30.96	27.00
Fibroblast - Lung, donor1	11270-116H1	78.84	19.03	21.75
Fibroblast - Lung, donor2	11347-117G6	196.96	62.67	52.23
Fibroblast - Lung, donor3	11419-118F6	112.06	36.93	46.64
Fibroblast - Lymphatic, donor1	11506-119G3	326.54	28.32	34.99
Fibroblast - Lymphatic, donor2	11586-120G2	121.68	6.99	20.98
Fibroblast - Lymphatic, donor3	11667-122G2	113.35	9.24	14.55
Fibroblast - Mammary, donor1	11540-120B1	199.74	50.34	49.12
Fibroblast - Mammary, donor2	11620-122A9	87.87	15.98	31.95
Fibroblast - Mammary, donor3	11701-123A9	148.91	5.96	29.78
Fibroblast - Periodontal Ligament, donor1	11238-116D5	424.61	85.54	88.65
Fibroblast - Periodontal Ligament, donor2	11319-117D5	169.58	50.21	55.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	395.95	52.02	41.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	242.71	36.25	37.40
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	294.56	45.36	35.37
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	234.85	18.79	16.47
Fibroblast - Pulmonary Artery, donor1	11250-116E8	635.89	89.64	64.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	424.67	34.14	36.57
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	128.96	28.73	48.78
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	252.24	63.26	58.12
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	162.93	22.23	29.17
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	194.14	29.31	30.20
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	335.64	40.01	40.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	209.70	24.97	28.28
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	402.66	36.92	42.21
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	211.32	23.03	31.63
Fibroblast - skin normal, donor1	11553-120C5	349.49	44.96	36.59
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	201.11	33.69	27.07
Fibroblast - skin normal, donor2	11561-120D4	404.26	54.85	58.87
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	249.04	25.99	40.20
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	349.53	48.30	33.47
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	651.66	31.63	39.66
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	131.37	12.15	22.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	388.48	50.49	56.14
Fibroblast - skin walker warburg, donor1	11554-120C6	327.41	63.09	70.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	769.67	106.32	99.11
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2149.50	775.59	531.84
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	291.09	36.60	30.50
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1063.90	73.50	68.13
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	636.81	78.33	54.91
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	744.56	60.05	47.78
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	199.81	31.39	73.49
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	276.29	50.41	96.35
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	385.68	180.00	229.07
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	53.22	66.73	72.80
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	104.80	48.41	48.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	204.87	89.36	121.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	50.75	69.52	83.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	102.41	41.09	42.07
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	336.97	111.88	207.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	68.12	52.57	105.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	72.78	37.44	66.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	127.60	61.52	67.16
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	77.93	53.65	101.59
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	80.56	54.12	107.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	151.66	74.41	104.29
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	89.67	53.39	69.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	68.01	46.09	80.72
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	88.52	37.60	61.20
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	80.96	59.39	72.69
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	64.22	40.06	78.05
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	86.24	45.35	62.33
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	63.51	46.78	50.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	92.12	54.96	83.46
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	188.43	67.48	73.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.71	52.03	55.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	72.24	50.21	70.70
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	58.43	39.50	57.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	175.04	65.73	70.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	151.30	57.17	77.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	86.03	63.95	75.71
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	52.23	39.32	60.30
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	109.90	48.53	56.53
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	53.34	33.95	45.41
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	55.96	48.09	74.78
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	105.36	45.39	57.71
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	48.75	39.45	49.39
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	48.04	31.84	43.40
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	84.62	42.87	50.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	100.35	50.17	54.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	80.18	38.05	53.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	83.65	42.59	50.72
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	90.90	40.68	51.62
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	94.16	33.42	42.78
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	183.71	62.04	64.18
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	209.46	51.87	43.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	123.71	40.42	55.70
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	123.61	40.93	41.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	128.49	39.64	42.03
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	125.67	50.66	44.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	38.68	16.86	16.86
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	165.15	44.19	44.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	175.33	48.02	47.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	71.67	17.54	12.71
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	123.42	59.32	125.21
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	49.15	50.23	111.09
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	53.40	58.72	119.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	406.50	133.62	145.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	403.49	127.43	140.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	127.75	56.27	103.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	277.18	94.04	108.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	238.66	74.65	92.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	341.75	97.87	88.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	163.45	50.43	92.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	230.11	67.05	83.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	221.55	71.65	99.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	149.95	53.32	99.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	210.02	63.48	87.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	176.82	60.79	77.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	103.18	54.52	62.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	163.81	58.84	84.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	186.81	70.65	97.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	265.19	127.38	156.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	115.11	78.46	119.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	86.13	51.50	74.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	194.83	86.40	93.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	213.32	57.57	77.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	146.59	53.62	56.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	216.01	79.03	100.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	143.77	52.66	66.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	145.38	46.94	64.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	197.98	66.88	109.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	89.77	62.80	90.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	110.92	49.98	71.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	54.67	121.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	80.69	74.08	117.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	63.37	54.92	105.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	132.26	82.91	123.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	111.67	63.02	103.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	101.14	82.88	138.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	103.88	108.60	188.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	100.35	84.02	139.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	58.81	46.08	104.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	68.66	102.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	117.00	51.93	70.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	139.27	45.61	65.02
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	178.04	36.52	30.82
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	127.24	17.88	18.30
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	384.56	40.48	34.86
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	228.99	19.03	20.93
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	362.60	30.08	25.06
Hep-2 cells mock treated, biol_rep1	11898-125E8	734.31	72.76	86.57
Hep-2 cells mock treated, biol_rep2	11899-125E9	580.68	66.68	78.16
Hep-2 cells mock treated, biol_rep3	11900-125F1	568.76	57.10	91.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	780.47	79.14	91.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	574.03	62.11	89.62
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	555.21	60.92	86.97
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	737.01	69.12	88.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	625.47	68.79	88.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	586.60	71.44	93.87
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	80.03	17.35	27.98
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	90.02	18.18	32.03
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	288.17	60.81	31.73
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	244.44	30.33	40.21
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	128.59	19.62	21.80
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	393.91	60.14	57.17
Hepatocyte, donor1	11523-119I2	225.17	35.11	26.63
Hepatocyte, donor2	11603-120I1	151.90	24.78	47.40
Hepatocyte, donor3	11684-122I1	141.11	19.02	20.25
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	590.03	76.36	80.93
Intestinal epithelial cells (polarized), donor1	11246-116E4	429.96	45.97	42.82
Iris Pigment Epithelial Cells, donor1	11530-119I9	367.58	71.48	68.05
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	19.10	28.66
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	26.70	46.73
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	81.25
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	11.08	30.46
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	20.02	10.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	130.55	35.60	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	10.25	23.07
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	9.14	27.42
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	37.36	16.24	40.61
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	21.67	21.67	16.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	10.89	36.31
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	38.38	9.26	33.09
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	32.15	17.74	24.39
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	73.34	5.24	20.95
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	35.90	33.38	54.17
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	12.37	18.56
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	29.27	43.90
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.30	23.26	43.28
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	25.76	14.49	28.98
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	35.84	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	40.74	21.19	47.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	33.17	20.15	14.69
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	28.74
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	38.58	20.90	31.34
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	29.55	24.01	23.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	45.24
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	35.40	20.30	34.46
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	30.84	15.42	25.40
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	35.51	19.37	24.75
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	17.79	30.49
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.14	14.03	33.16
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	18.23	16.40	30.99
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	22.14	14.28	23.56
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	26.55	36.50
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	48.77	30.87	50.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	12.29	15.80
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	9.43	22.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	24.34	13.21	26.42
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	13.28	30.98
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	22.69	25.94
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	14.82	9.59	22.67
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	9.00	20.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	20.91	27.88
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	24.54	19.20	39.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	22.17	15.24	19.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	17.10	31.35
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	13.81	31.29
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	12.10	33.28
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	37.25	31.04
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	8.46	27.49
Keratinocyte - epidermal, donor1	11272-116H3	382.37	24.72	23.26
Keratinocyte - epidermal, donor2	11349-117G8	151.09	26.35	33.97
Keratinocyte - epidermal, donor3	11421-118F8	482.56	73.07	79.23
Keratinocyte - oral, donor1	11251-116E9	423.42	107.05	111.70
Keratocytes, donor1	11527-119I6	151.63	29.91	40.57
Keratocytes, donor2	11607-120I5	419.50	37.50	56.25
Keratocytes, donor3	11688-122I5	455.86	33.00	35.57
Krukenberg tumor cell line:HSKTC	10687-109F3	90.11	37.36	24.18
Lens Epithelial Cells, donor1	11529-119I8	224.38	53.94	77.67
Lens Epithelial Cells, donor2	11609-120I7	136.09	60.32	52.71
Lens Epithelial Cells, donor3	11690-122I7	273.97	43.29	33.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	259.21	72.09	55.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	165.77	35.72	44.65
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	219.27	40.45	49.11
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	165.62	39.79	58.07
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	155.69	35.30	39.71
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	216.92	38.81	50.89
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	128.04	25.03	41.04
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	150.17	27.05	38.93
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	190.15	36.74	42.08
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	192.62	43.90	57.75
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	190.78	34.71	45.95
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	147.38	24.62	34.81
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	164.80	35.54	44.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	154.09	28.86	40.07
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	170.86	36.67	38.73
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	152.13	28.33	45.58
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	159.61	28.99	35.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	178.42	37.15	39.71
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	142.50	28.30	44.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	161.96	27.24	35.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	156.33	25.64	33.36
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	148.88	39.28	60.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	204.40	43.09	45.51
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	194.07	33.61	44.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	195.44	30.59	61.17
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	190.34	38.11	40.62
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	155.94	29.47	37.29
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	201.55	35.77	49.53
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	192.48	37.44	42.71
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	153.11	32.34	35.84
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	145.37	27.14	38.77
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	195.50	37.05	43.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	156.85	29.86	34.57
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	155.49	33.69	43.31
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	198.90	38.30	43.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	147.81	29.29	33.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	151.17	35.38	36.99
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	203.60	39.87	41.08
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	217.93	37.79	47.59
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	178.14	39.82	43.73
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	160.95	20.36	37.81
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	133.36	27.39	31.12
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	184.07	34.02	44.41
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	178.69	28.42	44.10
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	152.55	23.78	30.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	261.73	65.46	43.44
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	145.22	20.23	30.22
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	146.79	28.94	40.28
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	292.32	20.39	20.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	154.19	18.41	15.34
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	185.56	23.75	10.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	165.44	11.42	22.43
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	166.69	16.18	16.88
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	141.96	12.14	17.75
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	171.58	13.40	17.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	172.47	17.84	21.41
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	267.13	22.17	22.17
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	296.94	35.48	29.96
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	326.83	34.21	33.31
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	268.26	20.73	19.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	187.95	18.49	21.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	257.23	32.46	20.11
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	238.54	24.65	19.99
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	199.17	21.39	17.83
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	308.69	29.88	25.35
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	318.75	32.88	26.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	180.39	19.02	31.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	217.72	20.39	28.54
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	320.28	37.28	27.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	312.49	23.82	28.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	171.04	26.79	19.58
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	277.53	23.51	25.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	275.61	24.21	26.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	274.42	23.24	27.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	181.69	19.44	15.20
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	194.72	23.23	18.81
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	187.66	20.72	13.82
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	182.28	14.20	19.19
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	173.80	19.25	21.51
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	228.91	27.90	19.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	144.15	12.20	18.53
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	214.72	14.36	21.54
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	215.11	23.15	21.66
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	188.77	13.75	17.09
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	232.60	24.12	23.26
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	221.78	22.26	21.41
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	222.56	23.32	21.32
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	181.60	16.89	20.51
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	161.40	19.20	19.91
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	185.26	20.28	16.50
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	164.24	11.81	19.32
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	157.57	14.81	14.14
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	189.28	18.52	17.04
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	379.12	36.05	27.91
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	127.99	16.92	14.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	184.87	18.41	18.81
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	146.83	10.18	22.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	178.60	22.23	19.93
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	198.30	20.72	22.69
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	155.25	14.11	22.58
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	162.91	18.10	13.07
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	157.27	18.02	16.22
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	135.97	18.93	17.21
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	199.51	18.26	24.49
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	144.68	19.55	18.77
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	168.89	15.83	17.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	158.27	15.57	18.16
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	155.34	16.63	21.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	198.48	13.98	20.69
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	151.48	16.34	21.20
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	199.03	17.74	23.14
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	156.46	10.63	15.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	165.81	17.78	18.74
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	197.18	23.06	21.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	167.10	10.94	15.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	199.21	11.76	16.60
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	164.16	16.72	17.48
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	170.93	12.39	9.30
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	166.88	9.67	15.72
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	180.63	17.75	16.16
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	138.60	11.73	15.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	180.45	7.47	22.41
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	186.67	15.94	18.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	171.89	16.98	16.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	208.27	9.08	19.86
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	176.81	12.48	12.06
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	155.83	13.31	11.75
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	155.33	6.26	15.45
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	134.74	15.80	12.08
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	163.92	12.71	24.75
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	172.15	9.62	13.90
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	153.56	19.40	19.80
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	158.77	7.34	22.94
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	135.14	7.11	18.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	178.37	19.38	20.52
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	141.11	13.80	18.41
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	195.89	9.85	17.51
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	146.55	15.15	22.72
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	215.50	16.64	15.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	196.94	11.94	20.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	178.76	12.47	12.47
Macrophage - monocyte derived, donor1	11232-116C8	666.20	45.81	40.34
Macrophage - monocyte derived, donor2	11313-117C8	1376.12	35.78	26.61
Macrophage - monocyte derived, donor3	11389-118C3	467.30	22.55	26.35
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2317.91	134.88	81.25
Mallassez-derived cells, donor2	11929-125I3	536.99	85.88	76.69
Mallassez-derived cells, donor3	11930-125I4	789.87	114.11	136.07
Mammary Epithelial Cell, donor1	11273-116H4	814.29	77.62	74.83
Mammary Epithelial Cell, donor2	11350-117G9	564.33	71.52	90.34
Mammary Epithelial Cell, donor3	11422-118F9	193.80	26.19	22.20
Mast cell - stimulated, donor1	11487-119E2	216.26	25.76	29.15
Mast cell, donor1	11563-120D6	224.39	30.17	25.52
Mast cell, donor2	11565-120D8	439.22	58.54	36.26
Mast cell, donor3	11566-120D9	368.98	63.71	57.18
Mast cell, donor4	11567-120E1	401.74	43.61	33.33
Mast cell, expanded and stimulated, donor5	11940-126A5	1203.41	86.50	69.53
Mast cell, expanded and stimulated, donor8	11942-126A7	514.22	45.53	37.94
Mast cell, expanded, donor5	11939-126A4	545.39	65.62	69.41
Mast cell, expanded, donor8	11941-126A6	254.40	29.46	25.77
Melanocyte - dark, donor1	11502-119F8	216.51	78.90	70.44
Melanocyte - dark, donor2	11582-120F7	265.10	59.18	55.37
Melanocyte - dark, donor3	11663-122F7	192.19	52.23	37.09
Melanocyte - light, donor1	11274-116H5	54.77	8.70	10.11
Melanocyte - light, donor2	11351-117H1	44.36	8.19	10.24
Melanocyte - light, donor3	11423-118G1	66.78	6.07	6.07
Melanocyte, donor1 (MC+1)	12641-134G4	152.23	50.81	68.93
Melanocyte, donor2 (MC+2)	12739-135I3	197.67	33.35	43.84
Melanocyte, donor3 (MC+3)	12837-137B2	80.09	25.71	29.73
Meningeal Cells, donor1	11493-119E8	344.39	47.39	77.04
Meningeal Cells, donor2	11573-120E7	140.41	23.77	50.18
Meningeal Cells, donor3	11654-122E7	581.03	106.44	83.13
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	531.82	127.18	96.95
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	347.18	32.10	25.36
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	99.88	5.26	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	170.06	20.93	31.40
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	348.04	97.59	71.04
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	721.49	36.00	32.61
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	446.85	31.16	35.69
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	288.54	41.97	51.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	273.97	47.49	57.72
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	194.58	28.85	30.69
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	307.90	30.06	50.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	107.06	8.18	13.75
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	346.04	51.84	51.05
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	279.83	15.43	11.87
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	42.04	2.34	7.01
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	353.50	54.43	67.88
Mesenchymal stem cells - adipose, donor0	11217-116B2	551.52	93.22	104.56
Mesenchymal stem cells - hepatic, donor0	11218-116B3	325.55	46.28	49.41
Mesenchymal stem cells - umbilical, donor0	11214-116A8	354.14	78.37	102.32
Mesothelial Cells, donor1	11247-116E5	1297.50	25.46	31.03
Mesothelial Cells, donor2	12156-128G5	1378.79	51.55	33.53
Mesothelial Cells, donor3	11402-118D7	385.24	12.07	12.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	259.26	9.45	13.50
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	501.41	30.29	32.02
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	394.28	18.85	15.61
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	69.14	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	556.97	30.06	44.32
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	394.12	13.69	17.01
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	69.48	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	446.47	26.78	38.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	306.75	10.24	11.64
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	409.28	25.00	32.31
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	334.59	9.50	12.67
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	441.58	21.24	46.02
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	692.25	19.00	26.98
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	80.27	2.63	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	504.46	30.98	37.78
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	205.34	4.60	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	357.67	15.20	17.59
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	122.40	3.35	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	203.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	974.76	34.12	36.88
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	408.08	11.88	14.97
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	267.60	4.98	4.98
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	1844.96	42.37	46.51
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	686.34	14.72	18.30
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	986.33	28.54	32.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	1542.96	45.48	53.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	626.64	11.11	11.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	288.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1504.43	28.91	33.07
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	488.20	10.65	4.06
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	369.51	4.97	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1815.03	34.79	31.53
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1063.40	11.47	12.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	507.00	8.72	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1850.61	31.24	43.25
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1726.59	14.81	15.21
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	601.96	12.34	5.48
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	1840.12	27.03	39.55
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	5982.27	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	509.63	8.15	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4466.80	38.10	58.24
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	512.10	2.21	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	731.32	8.33	6.40
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5586.11	51.07	62.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	837.16	6.96	9.05
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	592.25	0.00	6.63
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5021.14	54.70	76.24
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1053.78	11.82	5.69
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	697.41	6.75	6.75
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6898.20	47.41	53.87
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1628.43	10.81	11.64
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	689.97	4.66	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2983.17	24.43	34.69
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3008.55	19.20	25.46
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	548.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	3378.36	31.40	40.64
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2563.88	18.21	18.78
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1235.89	17.00	23.35
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3841.62	37.84	52.87
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2019.19	12.87	21.45
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	506.25	6.99	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	1796.96	17.61	23.75
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	2399.42	15.57	32.93
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	724.35	13.14	16.10
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3361.91	37.90	65.30
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	3311.87	23.00	34.05
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	878.61	9.48	12.51
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3089.37	40.63	50.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	4535.08	33.18	49.90
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	422.93	7.82	11.73
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	1959.69	37.64	47.34
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	2899.70	29.41	37.48
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	1557.08	41.21	30.50
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	1317.09	25.01	39.90
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	791.04	75.34	124.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	504.38	55.25	44.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	269.76	25.96	50.93
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	603.82	45.23	66.27
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1113.37	65.43	63.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	599.77	31.66	37.25
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	297.42	21.03	33.42
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	489.27	24.77	36.76
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	554.08	61.07	76.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	232.07	16.21	38.31
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	221.32	24.92	39.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	404.45	45.11	52.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1333.42	119.71	158.19
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	239.56	11.59	19.32
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	110.08	16.16	19.19
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	612.22	45.54	59.87
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1796.40	202.93	249.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1686.13	125.25	173.57
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1790.55	174.92	230.80
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1314.08	84.58	132.92
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	177.02	5.71	28.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	1572.50	97.87	101.14
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	1924.75	61.78	57.03
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	288.63	12.55	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	475.68	47.18	29.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	143.20	15.16	19.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	106.13	10.68	6.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	77.63	14.19	9.60
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	327.80	84.04	74.16
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	193.10	67.03	49.47
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	48.28	8.84	9.52
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	479.62	141.50	86.37
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	67.38	10.04	7.95
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	201.29	30.91	30.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	67.02	11.62	7.84
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	116.47	18.29	20.39
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	289.50	200.42	77.94
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	132.03	14.39	14.39
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	119.09	18.41	20.57
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	117.65	13.60	15.19
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	69.73	8.98	9.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	135.23	25.15	16.59
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	87.52	6.37	7.96
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	65.43	4.80	4.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	247.45	38.07	38.07
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	68.14	5.20	6.99
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	103.89	19.05	11.82
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	65.40	11.95	12.66
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	70.34	8.27	6.44
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	80.01	6.11	13.50
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	276.60	55.53	40.35
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	273.07	85.97	58.15
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	91.34	13.81	12.25
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	58.43	9.31	5.93
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	97.79	14.48	11.87
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	81.99	8.16	8.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	180.56	72.22	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	61.65	6.00	7.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	74.84	6.31	3.16
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	97.22	9.52	10.32
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	94.72	4.64	5.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	136.21	18.54	19.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	62.24	5.54	5.87
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	41.40	2.61	5.23
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	90.01	14.02	15.83
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	80.25	5.29	7.06
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	83.77	5.98	6.65
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	61.51	4.46	9.42
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	44.02	3.06	4.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	138.22	20.57	17.54
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	93.49	15.25	13.70
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	50.82	4.07	5.42
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	306.57	97.08	40.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	78.04	7.93	5.49
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	41.55	3.15	3.15
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	36.32	5.15	3.93
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	53.80	14.24	12.66
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	167.78	48.75	20.41
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	429.92	156.79	91.04
Myoblast, donor1	11241-116D8	1274.96	66.59	44.72
Myoblast, donor2	11322-117D8	529.14	42.58	29.92
Myoblast, donor3	11398-118D3	685.43	62.05	36.83
NK T cell leukemia cell line:KHYG-1	10777-110G3	536.45	48.60	61.00
Natural Killer Cells, donor1	11230-116C6	30.44	15.99	13.53
Natural Killer Cells, donor2	11311-117C6	21.11	8.75	10.86
Natural Killer Cells, donor3	11387-118C1	17.49	11.60	11.41
Neural stem cells, donor1	11275-116H6	154.25	46.82	25.77
Neural stem cells, donor2	11352-117H2	119.39	46.22	38.51
Neurons, donor1	11494-119E9	125.17	63.72	84.20
Neurons, donor2	11574-120E8	177.89	64.73	64.29
Neurons, donor3	11655-122E8	142.23	50.15	75.64
Neutrophils, donor1	11233-116C9	125.28	68.67	64.03
Neutrophils, donor2	11314-117C9	49.28	37.69	55.08
Neutrophils, donor3	11390-118C4	343.29	142.33	163.09
Nucleus Pulposus Cell, donor1	11252-116F1	389.10	38.35	23.15
Nucleus Pulposus Cell, donor2	11409-118E5	203.50	31.26	17.26
Nucleus Pulposus Cell, donor3	11462-119B4	215.19	23.46	38.31
Olfactory epithelial cells, donor1	11933-125I7	221.07	25.19	18.31
Olfactory epithelial cells, donor2	11934-125I8	627.18	48.34	29.38
Olfactory epithelial cells, donor3	11935-125I9	403.17	27.35	21.45
Olfactory epithelial cells, donor4	11936-126A1	185.74	32.82	27.08
Oligodendrocyte - precursors, donor1	11496-119F2	273.23	67.40	85.46
Osteoblast - differentiated, donor1	11276-116H7	172.92	19.14	12.55
Osteoblast - differentiated, donor2	11353-117H3	107.45	12.57	6.86
Osteoblast - differentiated, donor3	11425-118G3	140.90	17.38	9.31
Osteoblast, donor1	11277-116H8	133.87	20.33	15.05
Osteoblast, donor2	11354-117H4	249.32	58.99	45.65
Osteoblast, donor3	11426-118G4	121.57	22.04	25.24
Pancreatic stromal cells, donor1	11249-116E7	718.19	72.53	47.00
Pericytes, donor1	11491-119E6	246.45	15.24	18.25
Pericytes, donor2	11571-120E5	117.71	14.49	23.09
Pericytes, donor3	11652-122E5	343.63	42.93	49.03
Perineurial Cells, donor1	11499-119F5	332.51	92.34	78.10
Perineurial Cells, donor2	11579-120F4	354.06	83.27	57.05
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	45.58	17.53	17.53
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.67	13.71	15.18
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	16.18	9.06	9.71
Placental Epithelial Cells, donor1	11278-116H9	532.86	56.68	64.81
Placental Epithelial Cells, donor2	11355-117H5	160.79	16.63	39.92
Placental Epithelial Cells, donor3	11427-118G5	84.81	14.53	22.38
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	325.31	35.13	48.10
Preadipocyte - breast, donor1	11467-119B9	502.17	33.95	28.33
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	240.17	36.29	22.45
Preadipocyte - breast, donor2	11328-117E5	313.86	39.85	34.45
Preadipocyte - omental, donor1	11468-119C1	1129.84	48.48	35.16
Preadipocyte - omental, donor2	11329-117E6	648.16	59.80	49.32
Preadipocyte - omental, donor3	11403-118D8	261.29	31.80	30.94
Preadipocyte - perirenal, donor1	11469-119C2	314.97	26.58	40.35
Preadipocyte - subcutaneous, donor1	11279-116I1	130.83	12.59	11.06
Preadipocyte - subcutaneous, donor2	11356-117H6	251.63	60.91	51.53
Preadipocyte - subcutaneous, donor3	11428-118G6	309.24	54.83	48.36
Preadipocyte - visceral, donor1	11280-116I2	749.84	95.48	70.42
Preadipocyte - visceral, donor2	11357-117H7	387.01	52.46	44.18
Preadipocyte - visceral, donor3	11429-118G7	374.29	52.35	63.43
Prostate Epithelial Cells (polarized), donor1	11253-116F2	466.13	50.99	39.83
Prostate Epithelial Cells, donor2	11331-117E8	434.81	25.05	25.32
Prostate Epithelial Cells, donor3	11404-118D9	185.37	23.82	44.83
Prostate Stromal Cells, donor1	11254-116F3	1298.58	60.03	36.68
Prostate Stromal Cells, donor2	11332-117E9	653.72	46.98	42.14
Prostate Stromal Cells, donor3	11405-118E1	803.03	37.64	32.22
Renal Cortical Epithelial Cells, donor1	11516-119H4	137.23	30.29	53.65
Renal Cortical Epithelial Cells, donor2	11596-120H3	204.26	71.18	83.66
Renal Epithelial Cells, donor1	11517-119H5	68.98	13.70	17.25
Renal Epithelial Cells, donor2	11597-120H4	96.03	29.88	32.72
Renal Epithelial Cells, donor3	11678-122H4	165.04	74.11	80.46
Renal Glomerular Endothelial Cells, donor1	11514-119H2	61.96	14.30	19.06
Renal Glomerular Endothelial Cells, donor2	11594-120H1	191.23	25.07	57.01
Renal Glomerular Endothelial Cells, donor3	11675-122H1	123.66	41.74	54.17
Renal Glomerular Endothelial Cells, donor4	11783-124B1	36.60	5.32	9.98
Renal Mesangial Cells, donor1	11518-119H6	199.84	40.94	41.38
Renal Mesangial Cells, donor2	11598-120H5	88.40	25.71	45.14
Renal Mesangial Cells, donor3	11679-122H5	73.24	14.15	18.59
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	204.54	41.34	73.01
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	107.95	23.61	44.28
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	118.41	36.45	44.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	241.39	52.63	65.60
Retinal Pigment Epithelial Cells, donor1	11528-119I7	112.84	26.43	28.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	68.95	13.38	24.70
Retinal Pigment Epithelial Cells, donor3	11689-122I6	194.96	31.61	22.58
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	191.37	24.86	24.32
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	204.59	44.67	80.41
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	294.45	64.39	121.08
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	131.67	35.38	95.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	392.42	98.30	153.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	258.39	77.06	90.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	522.00	167.53	151.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	454.37	157.04	202.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	306.86	89.62	116.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	387.61	121.34	146.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	239.86	65.99	100.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	328.57	96.66	121.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	530.05	147.29	147.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	266.83	72.73	113.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	305.09	106.24	125.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	396.07	115.06	146.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	237.82	48.18	101.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	254.43	83.29	99.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	431.43	143.56	123.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	216.84	52.82	98.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	235.47	85.27	110.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	326.35	106.75	122.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	245.52	68.67	117.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	296.84	102.87	125.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	275.32	93.31	104.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	265.47	61.26	107.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	223.07	80.32	89.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	314.31	100.07	124.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	373.62	75.72	166.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	283.93	90.67	106.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	422.79	128.15	164.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	317.88	78.59	126.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	352.39	104.41	125.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	240.43	83.76	100.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	277.24	67.97	116.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	249.99	75.61	95.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	271.84	78.85	103.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	346.11	74.62	143.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	249.78	75.72	79.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	391.87	119.68	143.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	240.48	57.26	104.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	243.39	84.48	98.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	217.77	94.36	95.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	186.11	52.82	90.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	252.63	83.34	119.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	191.87	88.28	81.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	271.41	64.13	108.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	292.77	77.21	74.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	188.28	67.39	35.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	354.92	70.25	112.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	592.98	219.06	134.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	344.37	139.94	111.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	426.78	70.83	129.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	172.58	52.70	62.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	161.45	82.97	76.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	324.82	54.55	75.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	197.44	56.14	65.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	260.82	114.79	120.80
Schwann Cells, donor1	11498-119F4	98.36	17.68	36.30
Schwann Cells, donor2	11578-120F3	193.94	71.45	85.06
Schwann Cells, donor3	11659-122F3	187.10	53.89	53.46
Sebocyte, donor1	11220-116B5	327.57	31.22	32.32
Sebocyte, donor2	11301-117B5	286.76	25.28	28.95
Sebocyte, donor3	11378-118B1	172.52	19.99	21.23
Sertoli Cells, donor1	11255-116F4	846.52	49.70	57.98
Sertoli Cells, donor2	11333-117F1	497.09	64.96	53.66
Skeletal Muscle Cells, donor1	11281-116I3	131.44	23.49	25.60
Skeletal Muscle Cells, donor2	11358-117H8	43.37	5.78	5.06
Skeletal Muscle Cells, donor3	11430-118G8	85.28	17.56	25.92
Skeletal Muscle Cells, donor4	11451-119A2	365.87	72.26	99.44
Skeletal Muscle Cells, donor5	11455-119A6	267.41	58.71	97.51
Skeletal Muscle Cells, donor6	11459-119B1	277.49	68.02	117.74
Skeletal Muscle Satellite Cells, donor1	11240-116D7	328.12	84.80	80.27
Skeletal Muscle Satellite Cells, donor2	11321-117D7	182.93	60.07	70.06
Skeletal Muscle Satellite Cells, donor3	11397-118D2	232.35	62.50	73.91
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	192.68	21.23	18.28
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	98.43	22.44	25.33
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	190.85	12.66	16.65
Skin - palm, donor1	10286-104F7	120.87	18.80	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	248.67	16.43	24.07
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	89.15	4.91	36.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	236.16	18.95	26.10
Small Airway Epithelial Cells, donor1	11256-116F5	797.49	50.74	57.69
Small Airway Epithelial Cells, donor2	11334-117F2	244.88	24.33	22.51
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	259.87	26.85	19.03
Small Airway Epithelial Cells, donor3	11406-118E2	139.48	13.94	16.94
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	503.30	29.93	66.04
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	159.86	12.23	19.12
Smooth Muscle Cells - Aortic, donor0	11210-116A4	259.23	31.74	32.92
Smooth Muscle Cells - Aortic, donor1	11283-116I5	184.97	22.98	17.46
Smooth Muscle Cells - Aortic, donor2	11360-117I1	248.08	16.93	15.75
Smooth Muscle Cells - Aortic, donor3	11432-118H1	296.67	41.72	33.99
Smooth Muscle Cells - Bladder, donor1	11519-119H7	257.19	24.02	33.02
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	204.81	28.08	24.75
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	531.75	43.44	34.80
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	258.75	34.18	37.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	432.06	81.40	56.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	393.08	70.58	43.71
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	250.70	33.31	44.70
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	285.98	40.51	40.83
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	128.78	22.53	25.57
Smooth Muscle Cells - Carotid, donor1	11285-116I7	691.52	34.60	24.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	12.24	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	99.66	13.83	23.36
Smooth Muscle Cells - Colonic, donor1	11239-116D6	564.68	66.51	67.25
Smooth Muscle Cells - Colonic, donor2	11320-117D6	289.93	41.11	57.04
Smooth Muscle Cells - Colonic, donor3	11396-118D1	308.79	49.44	64.97
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	242.85	16.09	13.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	331.99	30.18	16.17
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	247.15	21.82	41.84
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	162.51	22.53	32.77
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	327.39	54.50	46.80
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	506.53	37.84	21.94
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	250.31	30.04	22.30
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	152.16	11.47	30.79
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	604.30	117.63	111.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	518.26	30.63	40.48
Smooth Muscle Cells - Prostate, donor2	11335-117F3	529.80	30.05	26.30
Smooth Muscle Cells - Prostate, donor3	11465-119B7	700.36	49.21	30.44
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	696.57	49.00	44.33
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	232.55	22.51	19.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	60.73	6.46	19.38
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	322.76	40.00	33.02
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	234.77	37.87	25.24
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	178.32	11.91	16.30
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	300.90	32.45	33.33
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	384.46	89.30	68.89
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	145.75	40.64	31.77
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	286.11	31.81	35.26
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	208.55	25.75	21.93
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	109.62	16.92	21.44
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	313.59	85.66	104.53
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	561.30	80.60	81.02
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	141.43	7.14	18.57
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	236.10	26.42	23.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	478.35	33.81	44.19
Smooth Muscle Cells - Uterine, donor3	11466-119B8	954.39	149.51	104.74
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	455.97	18.85	21.57
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	562.49	28.30	37.02
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1929.66	41.66	64.72
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	1147.72	20.48	32.34
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1120.84	24.13	33.78
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	675.48	51.20	98.86
Smooth muscle cells - airway, control, donor1	11966-126D4	769.73	40.38	46.22
Smooth muscle cells - airway, control, donor2	11967-126D5	336.63	21.96	32.34
Smooth muscle cells - airway, control, donor3	11968-126D6	518.74	26.75	28.84
Smooth muscle cells - airway, control, donor4	11969-126D7	704.50	26.58	33.00
Synoviocyte, donor1	11291-117A4	343.04	45.45	37.54
Synoviocyte, donor2	11368-117I9	758.50	41.24	19.95
Synoviocyte, donor3	11440-118H9	323.72	20.33	14.75
Trabecular Meshwork Cells, donor1	11532-120A2	259.78	47.53	57.53
Trabecular Meshwork Cells, donor2	11612-122A1	152.62	9.91	15.86
Trabecular Meshwork Cells, donor3	11693-123A1	85.44	14.12	19.91
Tracheal Epithelial Cells, donor1	11292-117A5	403.73	44.37	48.17
Tracheal Epithelial Cells, donor2	11369-118A1	192.12	14.30	17.40
Tracheal Epithelial Cells, donor3	11441-118I1	124.27	12.03	17.75
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	180.35	27.31	24.11
Urethra, donor2	10319-105A4	34.17	10.79	12.59
Urothelial Cells, donor1	11520-119H8	431.43	43.04	52.07
Urothelial Cells, donor2	11600-120H7	241.94	35.65	44.46
Urothelial Cells, donor3	11681-122H7	124.00	18.57	23.84
Urothelial cells, donor0	11216-116B1	286.64	73.33	77.12
Whole blood (ribopure), donor090309, donation1	12179-129A1	94.32	19.58	59.62
Whole blood (ribopure), donor090309, donation2	12180-129A2	98.64	32.88	57.18
Whole blood (ribopure), donor090309, donation3	12181-129A3	45.86	12.32	25.33
Whole blood (ribopure), donor090325, donation1	12176-128I7	58.54	17.22	28.58
Whole blood (ribopure), donor090325, donation2	12177-128I8	74.37	15.11	23.82
Whole blood (ribopure), donor090612, donation1	12182-129A4	96.84	17.70	58.31
Whole blood (ribopure), donor090612, donation2	12183-129A5	81.68	19.27	55.99
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.95	9.13	24.65
Wilms' tumor cell line:G-401	10809-111A8	272.13	47.00	46.26
Wilms' tumor cell line:HFWT	10597-108E3	73.04	19.36	29.04
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	592.71	65.92	67.87
achilles tendon, donor2	10292-104G4	198.39	24.80	37.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	198.87	78.53	95.10
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	94.50	49.22	69.65
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	185.07	55.44	55.79
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	337.42	86.26	90.61
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	204.35	64.65	118.90
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	581.15	84.38	96.01
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	84.11	14.97	26.13
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	357.80	84.60	122.50
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	182.54	44.10	71.87
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	161.92	45.82	42.32
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	253.18	71.58	107.64
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	198.93	66.31	70.21
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	374.83	102.71	175.22
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	487.25	145.50	208.67
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	166.29	51.43	66.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	99.46	34.39	36.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	143.94	68.68	127.49
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	65.38	7.37	13.81
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	387.45	70.41	72.97
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	394.58	86.14	72.49
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	424.12	87.62	79.67
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	197.12	47.22	77.29
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	243.49	33.69	50.03
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	39.02	48.31	68.75
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	245.96	80.23	116.01
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	119.50	26.60	47.54
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	16.87	9.37
adenocarcinoma cell line:IM95m	10796-110I4	290.14	40.51	38.39
adipose tissue, adult, pool1	10010-101C1	77.56	26.68	21.10
adipose, donor1	10184-103D4	140.74	193.52	208.18
adipose, donor2	10185-103D5	57.99	29.20	45.42
adipose, donor3	10186-103D6	121.71	49.28	43.29
adipose, donor4	10187-103D7	134.35	58.94	89.28
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	65.50	21.15	18.46
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	543.50	120.73	134.74
alveolar cell carcinoma cell line:SW 1573	10708-109H6	418.04	98.26	108.98
amniotic membrane cells, donor1	12235-129G3	435.18	66.77	39.41
amniotic membrane cells, donor2	12236-129G4	195.09	55.11	55.11
amniotic membrane cells, donor3	12237-129G5	167.63	49.20	59.80
amygdala - adult, donor10196	10167-103B5	41.50	41.50	29.64
amygdala, adult, donor10252	10151-102I7	19.47	23.72	15.21
amygdala, newborn, donor10223	10360-105E9	86.18	20.98	25.82
anaplastic carcinoma cell line:8305C	10428-106D5	243.33	41.51	42.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	945.37	127.52	202.53
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	108.90	32.07	24.38
aorta, adult, pool1	10052-101G7	45.90	16.87	13.53
appendix, adult	10189-103D9	106.73	13.97	15.14
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	110.75	50.56	37.83
artery, adult	10190-103E1	36.68	10.87	17.66
astrocytoma cell line:TM-31	10425-106D2	240.62	70.84	61.86
b cell line:RPMI1788	10427-106D4	650.72	57.40	72.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	569.04	62.15	39.40
bile duct carcinoma cell line:HuCCT1	10432-106D9	375.00	39.39	34.93
bile duct carcinoma cell line:TFK-1	10496-107C1	849.78	9.71	4.85
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	162.74	26.84	26.84
bladder, adult, pool1	10011-101C2	104.95	32.81	32.38
blood, adult, pool1	10053-101G8	31.00	26.58	15.50
bone marrow stromal cell line:StromaNKtert	10686-109F2	1113.25	83.07	46.24
bone marrow, adult	10192-103E3	155.21	13.50	28.34
brain, adult, donor1	10084-102B3	30.75	25.63	16.40
brain, adult, pool1	10012-101C3	44.43	32.52	25.39
brain, fetal, pool1	10085-102B4	48.09	29.39	37.40
breast carcinoma cell line:MCF7	10482-107A5	266.60	32.38	15.53
breast carcinoma cell line:MDA-MB-453	10419-106C5	187.98	25.21	22.47
breast, adult, donor1	10080-102A8	23.99	9.47	15.78
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	599.24	34.55	23.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	154.92	58.75	55.66
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	113.04	72.06	137.90
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	239.42	30.50	30.99
carcinoid cell line:NCI-H1770	10703-109H1	53.13	56.89	119.42
carcinoid cell line:NCI-H727	10735-110B6	119.77	23.30	24.61
carcinoid cell line:SK-PN-DW	10719-109I8	270.31	96.34	156.55
carcinosarcoma cell line:JHUCS-1	10642-109A3	77.19	35.14	38.06
caudate nucleus - adult, donor10196	10177-103C6	29.93	18.42	19.57
caudate nucleus, adult, donor10252	10164-103B2	16.57	19.41	14.89
caudate nucleus, adult, donor10258	10379-105H1	27.51	12.23	22.16
caudate nucleus, newborn, donor10223	10354-105E3	97.78	19.41	28.20
cerebellum - adult, donor10196	10173-103C2	11.65	17.48	23.31
cerebellum, adult, donor10252	10166-103B4	15.37	14.09	15.16
cerebellum, adult, pool1	10083-102B2	22.77	20.70	19.66
cerebellum, newborn, donor10223	10357-105E6	92.99	14.11	24.08
cerebral meninges, adult	10188-103D8	39.33	30.76	20.93
cerebrospinal fluid, donor2	10294-104G6	89.90	10.23	14.62
cervical cancer cell line:D98-AH2	10552-107I3	539.33	108.56	97.20
cervical cancer cell line:ME-180	10553-107I4	957.68	77.72	60.16
cervix, adult, pool1	10013-101C4	174.91	25.83	19.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	360.05	28.15	18.25
chondrosarcoma cell line:SW 1353	10700-109G7	90.13	28.74	13.06
choriocarcinoma cell line:BeWo	10423-106C9	243.46	62.39	59.78
choriocarcinoma cell line:SCH	10785-110H2	181.74	14.29	15.28
choriocarcinoma cell line:T3M-3	10618-108G6	106.26	10.91	13.99
chorionic membrane cells, donor1	12238-129G6	737.09	56.41	45.02
chorionic membrane cells, donor2	12239-129G7	262.20	63.04	53.89
chorionic membrane cells, donor3	12240-129G8	767.63	59.34	43.96
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	437.24	47.46	126.23
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	349.43	83.56	88.37
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	141.71	51.32	39.91
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	74.73	55.47	70.62
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	69.66	46.20	61.92
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	73.10	51.11	64.34
chronic myelogenous leukemia cell line:K562	10454-106G4	329.50	121.32	148.70
chronic myelogenous leukemia cell line:KU812	10409-106B4	248.38	69.85	48.48
clear cell carcinoma cell line:JHOC-5	10638-108I8	309.27	72.69	99.20
clear cell carcinoma cell line:TEN	10636-108I6	213.93	52.40	33.83
colon carcinoma cell line:CACO-2	10513-107D9	692.63	75.96	71.57
colon carcinoma cell line:COLO-320	10420-106C6	158.87	83.24	117.83
colon, adult, donor1	10082-102B1	230.87	20.23	15.47
colon, adult, pool1	10014-101C5	339.70	29.61	19.15
colon, fetal, donor1	10070-101I7	131.01	14.83	17.30
common myeloid progenitor CMP, donor1	12130-128D6	18.33	13.75	13.75
common myeloid progenitor CMP, donor2	12134-128E1	851.25	150.22	75.11
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1928.77	39.94	27.20
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3338.30	45.73	29.73
cord blood derived cell line:COBL-a untreated	10449-106F8	3906.15	61.34	38.36
corpus callosum, adult, pool1	10042-101F6	37.70	11.61	9.07
cruciate ligament, donor2	10295-104G7	165.34	19.45	21.88
diaphragm, fetal, donor1	10069-101I6	32.10	18.46	14.45
diencephalon, adult	10193-103E4	44.16	24.72	21.60
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	115.26	56.03	72.56
ductal cell carcinoma cell line:KLM-1	10438-106E6	313.11	51.54	66.93
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	298.25	43.33	33.70
ductus deferens, adult	10196-103E7	66.78	16.45	23.92
duodenum, fetal, donor1, tech_rep1	10071-101I8	142.58	23.04	14.40
duodenum, fetal, donor1, tech_rep2	10071-101I8	178.03	19.86	27.22
dura mater, adult, donor1	10041-101F5	116.70	24.45	14.87
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	174.55	32.42	27.76
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	360.10	77.38	54.02
embryonic pancreas cell line:1B2C6	10604-108F1	228.15	57.96	64.13
embryonic pancreas cell line:1C3D3	10605-108F2	283.64	73.56	98.68
embryonic pancreas cell line:1C3IKEI	10606-108F3	326.66	50.94	67.00
embryonic pancreas cell line:2C6	10603-108E9	309.98	80.12	69.61
endometrial carcinoma cell line:OMC-2	10497-107C2	397.54	49.27	53.30
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	203.16	60.90	80.11
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	297.50	50.66	51.14
epidermoid carcinoma cell line:A431	10426-106D3	778.67	75.59	51.36
epidermoid carcinoma cell line:Ca Ski	10431-106D8	719.20	74.79	63.68
epididymis, adult	10197-103E8	86.03	18.21	20.51
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	242.16	59.96	54.82
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	175.39	16.12	21.24
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	725.23	87.15	74.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	526.45	57.58	47.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	629.83	73.38	63.63
esophagus, adult, pool1	10015-101C6	813.11	36.63	33.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	131.62	24.42	18.79
eye - muscle inferior rectus, donor1	10272-104E2	31.39	4.83	4.83
eye - muscle lateral, donor2	10298-104H1	46.29	8.42	8.42
eye - muscle medial, donor2	10299-104H2	16.37	8.93	4.46
eye - muscle superior, donor2	10297-104G9	85.99	16.05	17.20
eye - vitreous humor, donor1	10268-104D7	134.08	18.95	32.06
eye, fetal, donor1	10054-101G9	58.22	19.58	19.58
fibrosarcoma cell line:HT-1080	10758-110E2	198.36	51.55	71.16
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	165.72	41.79	60.78
frontal lobe, adult, pool1	10040-101F4	47.19	30.21	23.55
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	507.42	73.56	50.74
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	782.06	82.66	48.55
gall bladder, adult	10198-103E9	99.23	17.87	11.35
gamma delta positive T cells, donor1	11937-126A2	32.75	23.08	31.14
gamma delta positive T cells, donor2	11938-126A3	31.75	21.66	23.90
gastric adenocarcinoma cell line:MKN1	10614-108G2	965.05	51.33	36.33
gastric adenocarcinoma cell line:MKN45	10612-108F9	111.60	20.70	25.72
gastric cancer cell line:AZ521	10549-107H9	247.08	49.51	46.40
gastric cancer cell line:GSS	10560-108A2	112.57	56.74	96.10
gastrointestinal carcinoma cell line:ECC12	10615-108G3	115.83	21.02	24.90
giant cell carcinoma cell line:LU65	10487-107B1	436.93	138.72	180.60
giant cell carcinoma cell line:Lu99B	10433-106E1	513.37	80.90	77.96
glassy cell carcinoma cell line:HOKUG	10688-109F4	640.76	38.16	52.88
glioblastoma cell line:A172, tech_rep1	10444-106F3	272.22	43.70	41.48
glioblastoma cell line:A172, tech_rep2	10444-106F3	279.75	46.06	41.43
glioblastoma cell line:T98G	10485-107A8	634.87	53.53	39.96
glioma cell line:GI-1	10413-106B8	164.30	55.35	45.10
globus pallidus - adult, donor10196	10175-103C4	51.02	13.12	15.31
globus pallidus, adult, donor10252	10161-103A8	31.49	15.13	14.65
globus pallidus, adult, donor10258	10367-105F7	39.71	6.85	13.69
globus pallidus, newborn, donor10223	10364-105F4	108.18	10.13	20.25
granulocyte macrophage progenitor, donor1	12131-128D7	36.71	9.79	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	360.64	131.14	153.00
granulocyte macrophage progenitor, donor3	12139-128E6	449.49	167.25	78.40
granulosa cell tumor cell line:KGN	10624-108H3	84.16	28.16	30.08
hIPS +CCl2, biol_rep1	14383-156B9	110.19	67.95	143.70
hIPS +CCl2, biol_rep2	14384-156C1	70.42	48.01	120.72
hIPS +CCl2, biol_rep3	14385-156C2	70.85	47.02	135.26
hIPS, biol_rep1	14380-156B6	40.24	37.37	156.66
hIPS, biol_rep2	14381-156B7	61.04	28.12	103.57
hIPS, biol_rep3	14382-156B8	29.79	12.14	28.69
hairy cell leukemia cell line:Mo	10712-109I1	504.29	33.91	35.06
heart - mitral valve, adult	10205-103F7	43.95	8.97	15.25
heart - pulmonic valve, adult	10206-103F8	18.04	7.32	12.55
heart - tricuspid valve, adult	10207-103F9	55.79	5.83	16.65
heart, adult, diseased post-infarction, donor1	10050-101G5	67.13	17.55	15.51
heart, adult, diseased, donor1	10051-101G6	13.63	9.37	10.65
heart, adult, pool1	10016-101C7	26.91	16.56	14.49
heart, fetal, pool1	10046-101G1	28.96	15.20	16.02
hepatic mesenchymal tumor cell line:LI90	10778-110G4	107.98	18.20	26.22
hepatoblastoma cell line:HuH-6	10633-108I3	58.27	17.84	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	289.28	45.97	34.03
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	351.26	56.92	34.96
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	308.11	46.38	36.88
hepatoma cell line:Li-7	10484-107A7	815.43	71.73	66.40
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	447.33	76.98	82.91
hippocampus - adult, donor10196	10169-103B7	36.91	24.60	25.55
hippocampus, adult, donor10252	10153-102I9	22.04	17.14	13.67
hippocampus, adult, donor10258	10374-105G5	14.94	11.95	25.40
hippocampus, newborn, donor10223	10363-105F3	75.43	19.03	25.73
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	526.12	219.72	387.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	177.70	76.97	112.31
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	223.17	81.75	137.87
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	44.55	41.73	71.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	38.22	63.78	81.34
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.17	58.84	82.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	70.07	38.83	55.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	67.00	40.50	48.69
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	117.20	31.28	47.55
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	249.11	76.96	61.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	168.43	58.02	58.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	269.99	59.92	65.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	162.59	67.60	95.77
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	192.10	85.98	141.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	549.83	145.75	308.08
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	50.40	43.91	52.88
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.71	36.63	49.71
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	108.45	88.96	114.95
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	41.63	28.07	47.10
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	66.84	47.75	46.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	71.73	38.53	52.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	152.36	49.97	38.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	135.57	47.61	47.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	137.21	32.58	40.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	155.92	60.78	95.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	135.22	54.49	81.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	345.02	89.01	152.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	57.74	44.71	54.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	45.93	29.46	44.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	53.26	28.14	52.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	58.95	23.79	27.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	67.08	27.89	33.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	91.58	28.48	44.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	133.45	35.28	39.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	110.55	37.86	32.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	193.57	29.91	43.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	114.47	55.79	78.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	263.38	79.33	163.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	153.66	44.88	95.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	28.42	26.89	37.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	182.18	364.36	504.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	60.23	52.29	97.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	55.28	29.55	41.59
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	54.28	24.97	36.91
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	57.65	29.54	37.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	103.82	27.45	47.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	151.68	53.90	45.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	135.24	37.18	50.38
immature langerhans cells, donor1	11904-125F5	2294.09	131.24	100.73
immature langerhans cells, donor2	11905-125F6	962.44	68.12	56.24
insula, adult, pool1	10039-101F3	46.75	30.76	22.81
keratoacanthoma cell line:HKA-1	10791-110H8	800.84	56.25	53.32
kidney, adult, pool1	10017-101C8	336.13	37.85	24.33
kidney, fetal, pool1	10045-101F9	123.15	16.06	13.86
large cell lung carcinoma cell line:IA-LM	10509-107D5	181.50	52.83	52.97
large cell lung carcinoma cell line:NCI-H460	10839-111E2	1441.59	40.37	36.77
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	372.69	47.53	71.93
left atrium, adult, donor1	10079-102A7	24.52	4.90	17.98
left ventricle, adult, donor1	10078-102A6	29.33	14.66	19.21
leiomyoblastoma cell line:G-402	10721-110A1	76.06	21.07	15.05
leiomyoma cell line:10964C	10569-108B2	966.74	36.28	28.02
leiomyoma cell line:15242A	10570-108B3	1072.29	48.91	42.93
leiomyoma cell line:15425	10571-108B4	550.22	45.89	33.75
leiomyosarcoma cell line:Hs 5.T	10722-110A2	1098.44	101.59	31.75
lens epithelial cell line:SRA 01/04	10647-109A8	66.92	47.05	31.37
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	116.88	59.86	52.06
liposarcoma cell line:KMLS-1	10782-110G8	190.73	34.52	33.12
liposarcoma cell line:SW 872	10726-110A6	165.46	39.60	34.60
liver, adult, pool1	10018-101C9	257.52	34.52	27.06
liver, fetal, pool1	10086-102B5	129.82	8.47	16.93
locus coeruleus - adult, donor10196	10182-103D2	45.06	11.96	12.83
locus coeruleus, adult, donor10252	10165-103B3	45.58	21.22	15.69
locus coeruleus, adult, donor10258	10375-105G6	75.33	13.54	15.80
locus coeruleus, newborn, donor10223	10362-105F2	165.30	24.40	29.86
lung adenocarcinoma cell line:A549	10499-107C4	1231.85	22.97	21.04
lung adenocarcinoma cell line:PC-14	10408-106B3	910.02	62.05	59.29
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	142.23	40.99	35.46
lung, adult, pool1	10019-101D1	217.00	33.43	26.93
lung, fetal, donor1	10068-101I5	107.31	15.70	30.82
lung, right lower lobe, adult, donor1	10075-102A3	119.59	14.66	14.66
lymph node, adult, donor1	10077-102A5	63.90	9.47	14.20
lymphangiectasia cell line:DS-1	10727-110A7	122.96	41.42	66.85
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	72.60	61.88	68.67
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	666.85	85.80	71.36
mature adipocyte, donor1	12231-129F8	108.78	24.42	17.32
mature adipocyte, donor2	12232-129F9	185.32	40.05	26.15
mature adipocyte, donor3	12233-129G1	196.05	34.85	28.45
mature adipocyte, donor4	12234-129G2	138.72	34.22	26.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	625.19	56.23	30.50
medial frontal gyrus - adult, donor10196	10170-103B8	39.48	31.58	42.87
medial frontal gyrus, adult, donor10252	10150-102I6	18.76	18.76	13.06
medial frontal gyrus, adult, donor10258	10368-105F8	44.48	40.35	40.35
medial frontal gyrus, newborn, donor10223	10352-105E1	251.20	124.53	101.93
medial temporal gyrus - adult, donor10196	10183-103D3	45.23	41.68	30.88
medial temporal gyrus, adult, donor10252	10156-103A3	19.95	21.65	17.40
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	21.19	23.12
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	114.83	100.48
medial temporal gyrus, newborn, donor10223	10353-105E2	103.01	34.82	30.87
medulla oblongata - adult, donor10196	10174-103C3	49.32	11.68	18.82
medulla oblongata, adult, donor10252	10155-103A2	30.96	12.38	10.68
medulla oblongata, adult, pool1	10038-101F2	55.42	15.84	13.63
medulla oblongata, newborn, donor10223	10361-105F1	91.66	12.15	16.66
medulloblastoma cell line:D283 Med	10838-111E1	56.46	44.28	81.70
medulloblastoma cell line:ONS-76	10759-110E3	157.00	39.13	34.73
melanoma cell line:COLO 679	10514-107E1	129.08	15.09	13.94
melanoma cell line:G-361	10465-106H6	261.69	72.21	70.85
meningioma cell line:HKBMM	10691-109F7	292.70	58.61	60.06
merkel cell carcinoma cell line:MKL-1	10843-111E6	189.45	70.49	89.88
merkel cell carcinoma cell line:MS-1	10844-111E7	442.49	99.54	96.43
mesenchymal precursor cell - adipose, donor1	11747-123G1	396.78	63.98	58.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	302.48	39.45	47.63
mesenchymal precursor cell - adipose, donor3	11749-123G3	568.56	47.21	58.80
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	314.95	44.81	51.27
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	282.11	39.86	36.40
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	544.16	38.17	39.56
mesenchymal precursor cell - cardiac, donor1	11752-123G6	1025.52	57.33	61.62
mesenchymal precursor cell - cardiac, donor2	11753-123G7	534.82	38.07	34.85
mesenchymal precursor cell - cardiac, donor3	11754-123G8	393.53	78.92	70.17
mesenchymal precursor cell - cardiac, donor4	11755-123G9	751.77	74.54	65.36
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	222.21	50.93	68.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	167.64	23.71	28.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	239.11	55.35	62.41
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	805.68	72.26	85.18
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	487.14	66.97	73.09
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	186.92	23.72	31.63
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	486.73	46.45	66.73
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	804.58	24.40	28.04
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	910.02	68.81	86.01
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	308.29	55.14	56.19
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	286.31	49.98	63.63
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	353.07	43.44	76.58
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	205.46	30.33	42.07
mesenchymal stem cell line:Hu5/E18	10568-108B1	275.34	73.68	78.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	441.60	45.21	51.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	479.34	59.09	47.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	369.08	54.71	44.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	379.25	50.53	33.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	459.65	60.02	52.25
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	433.22	60.58	37.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	371.75	44.80	34.97
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	388.78	47.27	40.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	96.61	96.61
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	597.60	79.89	66.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	409.61	51.98	43.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	456.19	59.37	41.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	425.33	67.47	51.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	406.82	46.66	32.89
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	424.93	50.76	40.94
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	450.61	56.70	52.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	525.01	46.48	51.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	511.33	20.66	46.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	511.54	51.32	56.19
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	531.07	53.83	56.74
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	535.74	49.04	50.11
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	481.67	40.89	35.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	425.26	43.15	39.65
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	512.09	54.57	33.58
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	535.48	43.71	44.71
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	491.02	28.60	47.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	464.29	47.44	45.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	522.72	67.02	60.92
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	324.63	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	521.27	62.70	55.10
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	328.00	30.35	30.35
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	322.38	36.54	34.39
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	335.31	27.94	47.90
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	292.73	24.11	17.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	232.26	28.52	29.75
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	259.78	33.37	32.57
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	184.52	22.40	22.99
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	169.26	27.12	24.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	208.52	30.74	34.75
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	214.06	21.29	29.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	233.69	23.11	17.98
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	198.26	26.16	24.78
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	113.31	22.76	30.68
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	105.42	29.16	32.52
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	122.76	27.35	19.72
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	108.40	22.97	34.25
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	113.39	28.35	41.43
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	93.76	24.07	30.41
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	226.98	26.10	41.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	320.85	22.59	36.15
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	219.10	19.77	25.53
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	328.99	39.88	35.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	204.11	28.56	33.10
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	164.00	30.56	31.58
mesodermal tumor cell line:HIRS-BM	10696-109G3	161.71	26.31	17.80
mesothelioma cell line:ACC-MESO-1	10493-107B7	314.91	62.37	87.17
mesothelioma cell line:ACC-MESO-4	10494-107B8	211.75	43.32	42.63
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	730.78	25.64	64.10
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	2551.70	160.39	111.59
mesothelioma cell line:Mero-25	10850-111F4	212.20	26.55	44.94
mesothelioma cell line:Mero-41	10851-111F5	502.40	39.36	59.16
mesothelioma cell line:Mero-48a	10852-111F6	226.08	36.98	48.71
mesothelioma cell line:Mero-82	10853-111F7	250.45	27.86	38.63
mesothelioma cell line:Mero-83	10854-111F8	402.74	36.43	39.83
mesothelioma cell line:Mero-84	10855-111F9	261.87	27.05	68.25
mesothelioma cell line:Mero-95	10856-111G1	266.67	20.29	22.57
mesothelioma cell line:NCI-H2052	10847-111F1	263.71	29.65	33.13
mesothelioma cell line:NCI-H226	10846-111E9	376.64	28.05	38.73
mesothelioma cell line:NCI-H2452	10848-111F2	525.28	57.40	71.23
mesothelioma cell line:NCI-H28	10845-111E8	1111.76	66.42	98.22
mesothelioma cell line:No36	10857-111G2	217.58	42.08	56.11
mesothelioma cell line:ONE58	10858-111G3	991.96	58.80	102.96
migratory langerhans cells, donor1	11901-125F2	8921.71	191.35	177.91
migratory langerhans cells, donor2	11902-125F3	8845.55	92.32	86.58
migratory langerhans cells, donor3	11903-125F4	11418.19	177.33	148.43
mixed mullerian tumor cell line:HTMMT	10689-109F5	122.10	55.17	81.95
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	783.32	264.71	267.68
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	213.77	21.42	26.26
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	551.85	38.63	49.67
myelodysplastic syndrome cell line:SKM-1	10772-110F7	469.00	104.04	64.31
myeloma cell line:PCM6	10474-106I6	357.38	32.42	39.93
myxofibrosarcoma cell line:MFH-ino	10600-108E6	204.95	23.84	29.93
myxofibrosarcoma cell line:NMFH-1	10684-109E9	280.87	85.91	76.30
nasal epithelial cells, donor1, tech_rep1	12226-129F3	530.05	61.39	100.62
nasal epithelial cells, donor1, tech_rep2	12226-129F3	763.13	95.68	134.14
nasal epithelial cells, donor2	12227-129F4	544.81	51.34	57.96
neuroblastoma cell line:CHP-134	10508-107D4	130.90	54.29	51.30
neuroblastoma cell line:NB-1	10539-107G8	111.32	110.75	96.54
neuroblastoma cell line:NBsusSR	10607-108F4	63.48	39.23	28.05
neuroblastoma cell line:NH-12	10555-107I6	64.29	67.65	81.06
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	156.57	29.65	16.84
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	81.25	32.15	21.38
neuroectodermal tumor cell line:TASK1	10774-110F9	129.61	30.39	29.18
neuroepithelioma cell line:SK-N-MC	10728-110A8	92.19	27.97	27.97
neurofibroma cell line:Hs 53.T	10729-110A9	224.38	33.54	27.15
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00
neutrophil PMN, donor2	12137-128E4	278.89	13.28	106.25
neutrophil PMN, donor3	12141-128E8	265.18	94.71	142.06
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	42.62	40.93	44.31
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	2605.65	394.65	347.42
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	358.44	43.28	34.95
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	877.63	45.72	39.41
nucleus accumbens, adult, pool1	10037-101F1	40.12	23.90	15.94
occipital cortex - adult, donor10196	10172-103C1	30.91	12.36	30.91
occipital cortex, adult, donor10252	10163-103B1	23.08	9.93	15.57
occipital cortex, newborn, donor10223	10355-105E4	59.32	26.20	27.30
occipital lobe, adult, donor1	10076-102A4	35.42	27.03	25.45
occipital lobe, fetal, donor1	10073-102A1	63.51	33.04	43.77
occipital pole, adult, pool1	10036-101E9	18.45	11.83	13.72
olfactory region, adult	10195-103E6	35.34	26.17	20.63
optic nerve, donor1	10277-104E7	40.02	20.01	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	629.23	48.18	41.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	2513.62	182.04	189.59
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	486.64	49.44	34.37
oral squamous cell carcinoma cell line:SAS	10544-107H4	203.30	59.37	65.38
osteoclastoma cell line:Hs 706.T	10704-109H2	174.91	30.57	24.40
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	325.15	71.94	62.60
osteosarcoma cell line:HS-Os-1	10558-107I9	119.60	26.30	24.81
ovary, adult, pool1	10020-101D2	69.79	15.72	15.29
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	94.41	24.56	25.48
pancreas, adult, donor1	10049-101G4	73.37	22.58	19.75
pancreatic carcinoma cell line:NOR-P1	10698-109G5	88.89	10.90	11.46
papillary adenocarcinoma cell line:8505C	10437-106E5	600.32	101.70	75.98
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	627.56	68.05	65.57
paracentral gyrus, adult, pool1	10035-101E8	44.57	25.63	18.30
parietal cortex, adult, donor10258	10373-105G4	20.55	21.29	19.08
parietal lobe - adult, donor10196	10171-103B9	42.32	19.75	22.57
parietal lobe, adult, donor10252	10157-103A4	14.25	19.67	16.82
parietal lobe, adult, pool1	10034-101E7	30.58	19.74	15.77
parietal lobe, fetal, donor1	10072-101I9	67.89	41.70	54.31
parietal lobe, newborn, donor10223	10356-105E5	109.54	32.90	26.54
parotid gland, adult	10199-103F1	101.13	17.27	17.27
penis, adult	10200-103F2	70.90	21.48	13.43
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	95.39	16.36	23.80
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	453.84	24.33	23.75
pineal gland - adult, donor10196	10179-103C8	17.42	7.74	12.26
pineal gland, adult, donor10252	10160-103A7	11.25	13.03	15.40
pineal gland, adult, donor10258	10377-105G8	18.81	10.03	15.05
pituitary gland - adult, donor10196	10180-103C9	28.33	13.15	19.22
pituitary gland, adult, donor10252	10162-103A9	17.20	18.76	15.11
pituitary gland, adult, donor10258	10378-105G9	22.98	6.81	14.47
placenta, adult, pool1	10021-101D3	182.75	22.04	19.67
plasma cell leukemia cell line:ARH-77	10840-111E3	206.06	84.75	132.56
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	456.49	83.27	58.05
pons, adult, pool1	10033-101E6	139.95	27.11	17.04
postcentral gyrus, adult, pool1	10032-101E5	33.56	26.41	17.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	4.18	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	622.41	126.68	170.75
promyelocytes/myelocytes PMC, donor3	12140-128E7	657.20	140.83	82.15
prostate cancer cell line:DU145	10490-107B4	797.64	110.70	114.64
prostate cancer cell line:PC-3	10439-106E7	180.96	58.63	54.27
prostate, adult, pool1	10022-101D4	56.77	17.96	16.05
putamen, adult, donor10196	10176-103C5	31.40	29.98	21.72
putamen, adult, donor10252	10152-102I8	39.21	19.61	21.57
putamen, adult, donor10258, tech_rep1	10372-105G3	40.43	30.60	81.96
putamen, adult, donor10258, tech_rep2	10372-105G3	22.95	11.36	16.91
putamen, newborn, donor10223	10365-105F5	134.19	41.98	40.48
rectal cancer cell line:TT1TKB	10469-106I1	166.41	21.24	18.04
rectum, fetal, donor1	10067-101I4	76.50	9.74	23.65
renal cell carcinoma cell line:OS-RC-2	10411-106B6	238.71	54.48	61.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	93.20	48.46	97.75
retina, adult, pool1	10030-101E3	35.39	10.74	8.95
retinoblastoma cell line:Y79	10475-106I7	94.31	102.10	93.79
rhabdomyosarcoma cell line:KYM-1	10787-110H4	151.23	51.76	52.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	50.90	28.96	29.24
sacrococcigeal teratoma cell line:HTST	10695-109G2	286.47	18.19	21.98
salivary acinar cells, donor1	11771-123I7	181.28	26.87	23.47
salivary acinar cells, donor2	11772-123I8	166.60	21.89	13.36
salivary acinar cells, donor3	11773-123I9	39.06	9.27	4.63
salivary gland, adult, pool1	10093-102C3	144.70	18.30	32.60
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	163.56	32.88	24.62
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	167.28	40.44	29.27
seminal vesicle, adult	10201-103F3	66.66	19.05	13.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	233.94	42.51	42.75
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	259.18	77.00	126.57
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	425.50	88.31	126.45
serous cystadenocarcinoma cell line:HTOA	10693-109F9	103.70	13.03	9.67
signet ring carcinoma cell line:Kato III	10436-106E4	1565.96	52.50	30.51
signet ring carcinoma cell line:NUGC-4	10483-107A6	1073.75	41.03	37.55
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	8.51	8.51
skeletal muscle, adult, pool1	10023-101D5	61.17	16.91	10.79
skeletal muscle, fetal, donor1	10066-101I3	32.16	8.04	12.06
skin, adult, donor1	10074-102A2	156.06	20.36	6.79
skin, fetal, donor1	10065-101I2	103.52	26.51	18.94
small cell cervical cancer cell line:HCSC-1	10800-110I8	221.79	73.04	103.73
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	70.61	82.58	69.35
small cell lung carcinoma cell line:DMS 144	10841-111E4	30.26	29.88	60.72
small cell lung carcinoma cell line:LK-2	10541-107H1	900.62	158.23	120.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	9.81	19.95	57.91
small cell lung carcinoma cell line:WA-hT	10562-108A4	97.84	27.02	27.24
small intestine, adult, pool1	10024-101D6	379.11	32.85	24.72
small intestine, fetal, donor1	10064-101I1	197.29	29.73	18.67
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	323.13	85.14	66.16
smooth muscle, adult, pool1	10048-101G3	58.41	26.36	24.55
somatostatinoma cell line:QGP-1	10781-110G7	90.86	31.09	28.68
spinal cord - adult, donor10196	10181-103D1	55.52	17.21	14.45
spinal cord, adult, donor10252	10159-103A6	53.23	26.81	16.95
spinal cord, adult, donor10258	10369-105F9	50.50	30.44	42.89
spinal cord, fetal, donor1	10056-101H2	78.06	28.66	20.73
spinal cord, newborn, donor10223	10359-105E8	154.30	26.63	27.55
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	134.57	26.44	23.60
spleen, adult, pool1	10025-101D7	71.48	17.62	20.60
spleen, fetal, pool1	10044-101F8	56.57	11.28	12.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	272.86	51.86	53.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	627.16	63.23	69.68
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	145.37	30.75	24.81
squamous cell carcinoma cell line:T3M-5	10616-108G4	174.36	35.18	48.87
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	856.91	48.63	23.98
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	1092.05	77.10	94.46
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	189.11	41.04	70.23
stomach, fetal, donor1	10062-101H8	164.47	27.77	18.16
submaxillary gland, adult	10202-103F4	107.67	18.80	21.65
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	49.02	18.49	15.16
substantia nigra, adult, donor10258	10371-105G2	13.97	9.83	23.79
substantia nigra, newborn, donor10223	10358-105E7	108.11	12.01	24.02
synovial sarcoma cell line:HS-SY-II	10441-106E9	250.82	53.88	47.23
temporal lobe, adult, pool1	10031-101E4	30.69	21.53	17.55
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	58.41	38.46	40.60
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	68.13	33.84	40.00
tenocyte, donor1	11763-123H8	224.12	41.89	37.00
tenocyte, donor2	11765-123I1	468.87	41.97	37.01
tenocyte, donor3	11768-123I4	379.56	44.85	36.70
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	247.97	57.79	65.94
teratocarcinoma cell line:NCR-G1	10798-110I6	146.90	68.29	100.50
teratocarcinoma cell line:PA-1	10807-111A6	106.31	53.78	66.49
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	280.43	53.95	50.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	50.30	16.64	23.45
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	107.64	31.41	36.75
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	369.02	46.58	47.55
testis, adult, pool1	10026-101D8	51.32	16.32	14.92
testis, adult, pool2	10096-102C6	23.91	5.41	9.02
thalamus - adult, donor10196	10168-103B6	43.06	23.18	27.60
thalamus, adult, donor10252	10154-103A1	20.63	15.78	13.13
thalamus, adult, donor10258, tech_rep1	10370-105G1	35.41	10.78	40.03
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.95	11.03	12.85
thalamus, newborn, donor10223	10366-105F6	258.32	50.63	40.27
throat, adult	10209-103G2	758.00	24.47	16.48
throat, fetal, donor1	10061-101H7	68.25	15.54	12.49
thymic carcinoma cell line:Ty-82	10803-111A2	328.90	81.68	79.10
thymus, adult, pool1	10027-101D9	170.20	36.58	46.03
thymus, fetal, pool1	10043-101F7	125.10	25.25	30.76
thyroid carcinoma cell line:KHM-5M	10776-110G2	522.40	85.89	91.88
thyroid carcinoma cell line:TCO-1	10783-110G9	252.98	95.13	101.14
thyroid, adult, pool1	10028-101E1	91.63	15.12	16.61
thyroid, fetal, donor1	10060-101H6	64.86	14.50	11.34
tongue epidermis (fungiform papillae), donor1	10288-104F9	89.31	6.16	6.16
tongue, adult	10203-103F5	2304.38	30.24	20.23
tongue, fetal, donor1	10059-101H5	300.69	22.86	22.46
tonsil, adult, pool1	10047-101G2	553.57	23.94	16.53
trachea, adult, pool1	10029-101E2	319.59	35.01	22.66
trachea, fetal, donor1	10058-101H4	158.11	21.54	17.70
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	671.00	46.41	35.07
transitional-cell carcinoma cell line:5637	10418-106C4	434.65	89.36	62.11
transitional-cell carcinoma cell line:JMSU1	10492-107B6	300.37	71.14	79.28
tridermal teratoma cell line:HGRT	10694-109G1	167.42	30.44	7.61
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	174.21	18.96	19.89
umbilical cord, fetal, donor1	10057-101H3	54.25	8.35	10.43
uterus, adult, pool1	10100-102D1	82.24	13.14	18.09
uterus, fetal, donor1	10055-101H1	455.62	43.00	34.30
vagina, adult	10204-103F6	31.66	8.40	18.09
vein, adult	10191-103E2	49.98	9.21	12.49
xeroderma pigentosum b cell line:XPL 17	10563-108A5	177.05	40.86	53.41